Published in PLoS One on March 14, 2016
Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia (ROTAVAC) | NCT03602053
The infant gut microbiome correlates significantly with rotavirus vaccine response in rural Ghana. J Infect Dis (2016) 0.75
Contribution of maternal immunity to decreased rotavirus vaccine performance in low and middle income countries. Clin Vaccine Immunol (2016) 0.75
Characterization of rotavirus infection in children with acute gastroenteritis in Bengo province, Northwestern Angola, prior to vaccine introduction. PLoS One (2017) 0.75
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med (2006) 11.49
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med (2006) 9.93
Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis (2003) 9.44
Rotavirus and severe childhood diarrhea. Emerg Infect Dis (2006) 7.80
Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med (2010) 6.56
Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet (2007) 4.45
Child undernutrition, tropical enteropathy, toilets, and handwashing. Lancet (2009) 4.25
Global mortality associated with rotavirus disease among children in 2004. J Infect Dis (2009) 3.63
Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med (2010) 2.26
Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis (2009) 2.12
Rotavirus vaccines. Wkly Epidemiol Rec (2007) 1.89
Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. Bull World Health Organ (1998) 1.72
Chronic T cell-mediated enteropathy in rural west African children: relationship with nutritional status and small bowel function. Pediatr Res (2003) 1.68
The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis (2002) 1.53
Serum antibody as a marker of protection against natural rotavirus infection and disease. J Infect Dis (2000) 1.51
Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J (2010) 1.48
Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine--a randomized trial. PLoS One (2015) 1.46
Burden and epidemiology of rotavirus diarrhea in selected African countries: preliminary results from the African Rotavirus Surveillance Network. J Infect Dis (2010) 1.40
Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin (2010) 1.39
Rotavirus vaccines: targeting the developing world. J Infect Dis (2005) 1.35
Inhibitory effects of human and bovine milk constituents on rotavirus infections. J Dairy Sci (2004) 1.23
The protective effect of human milk against diarrhea. A review of studies from Bangladesh. Acta Paediatr Scand Suppl (1989) 1.18
Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections. J Infect Dis (1994) 1.18
Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries. Pediatr Infect Dis J (2013) 1.17
Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Organ (2014) 1.14
Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants. Vaccine (2013) 1.07
Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries? Vaccine (2010) 1.05
Global networks for surveillance of rotavirus gastroenteritis, 2001-200. Wkly Epidemiol Rec (2008) 0.96
Seroepidemiologic evaluation of antibodies to rotavirus as correlates of the risk of clinically significant rotavirus diarrhea in rural Bangladesh. J Infect Dis (1992) 0.96
WHO informal consultation on quality, safety and efficacy specifications for live attenuated rotavirus vaccines Mexico City, Mexico, 8-9 February 2005. Vaccine (2005) 0.91
Review of rotavirus studies in Africa: 1976-2006. J Infect Dis (2010) 0.89
Rotavirus gastro-enteritis in hospitalized children with acute diarrhoea in Zambia. Ann Trop Paediatr (1995) 0.88
Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants. Vaccine (2014) 0.86
Protein-energy malnutrition alters IgA responses to rotavirus vaccination and infection but does not impair vaccine efficacy in mice. Vaccine (2013) 0.84
Rotavirus-specific IgG antibodies from mothers' serum may inhibit infant immune responses to the pentavalent rotavirus vaccine. Pediatr Infect Dis J (2015) 0.83
Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants. Clin Infect Dis (2015) 0.82
Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group. Pediatr Infect Dis J (1996) 0.81
Measurement of antirotavirus IgM/IgA/IgG responses in the serum samples of Indian children following rotavirus diarrhoea and their mothers. J Med Virol (2004) 0.81
Serum antibody responses in children with rotavirus diarrhea can serve as proxy for protection. Clin Diagn Lab Immunol (2005) 0.80
Contribution of maternal immunity to decreased rotavirus vaccine performance in low and middle income countries. Clin Vaccine Immunol (2016) 0.75